$7.74
-0.07 (-0.90%)
Open$7.75
Previous Close$7.81
Day High$7.91
Day Low$7.60
52W High$16.10
52W Low$6.47
Volume—
Avg Volume101.1K
Market Cap52.71M
P/E Ratio—
EPS$-5.41
SectorBiotechnology
Analyst Ratings
Strong Buy
5 analysts
Price Target
+545.2% upside
Current
$7.74
$7.74
Target
$49.94
$49.94
$27.43
$49.94 avg
$65.11
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 35.65M | 12.59M | 12.91M |
| Net Income | -28,543,109 | -1,338,243 | -1,683,285 |
| Profit Margin | -80.1% | -10.6% | -13.0% |
| EBITDA | -32,048,857 | -1,969,871 | -1,762,148 |
| Free Cash Flow | — | -1,414,748 | -1,276,245 |
| Rev Growth | — | -1.9% | -7.4% |
| Debt/Equity | — | 1.05 | 0.93 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |